Literature DB >> 20037210

Apolipoprotein E genotypes in Mexican patients with Parkinson's disease.

M P Gallegos-Arreola1, L E Figuera, G G Ortiz, F J Jiménez-Gil, J Ramírez-Vega, J L Ruíz-Sandoval, A M Puebla-Pérez, R Troyo-Sanroman, J E García-Ortiz, J Sanchez-Corona, G M Zúñiga-González.   

Abstract

BACKGROUND: The association of the apolipoprotein (Apo E) -epsilon4 allele to neurodegenerative diseases such as Parkinson's disease (PD) has been analyzed in several studies. This association has been identified by amyloid deposits and neurofibrillary tangles in the brains of patients with neurodegenerative diseases.
METHOD: In this study the possible relationship between Apo E alleles and PD patients was analyzed in 105 patients with PD and 107 healthy controls from a Mexican population.
RESULTS: Allele analysis in PD vs. controls was: epsilon2 in 6% and 2.3%, respectively; epsilon3 in 73% and 88.3%; and epsilon4} in 21% and 9.4%. The epsilon3 allele showed a protective risk effect with an Odds ratio (OR) of 0.36 (95%CI 0.20-0.61) and p < 0.05; contrary results were observed for the epsilon4 allele, which showed an increased risk for PD, with an OR of 2.57(95% CI 1.42-4.79) and p < 0.05. Upon multivariate analysis showed PD risk was evident in patients who were carriers of the genotype epsilon3/epsilon4; age group (fifty or more years) and had exposure to pesticides and solvents (p < 0.05).
CONCLUSIONS: The epsilon3/epsilon3}; epsilon3/epsilon4 genotypes of the Apo E, were positively associated with sporadic PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20037210      PMCID: PMC3834675          DOI: 10.3233/DMA-2009-0667

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  5 in total

1.  A large study reveals no association between APOE and Parkinson's disease.

Authors:  Monica Federoff; Belen Jimenez-Rolando; Michael A Nalls; Andrew B Singleton
Journal:  Neurobiol Dis       Date:  2012-02-12       Impact factor: 5.996

2.  Impact of genetic variants of apolipoprotein E on lipid profile in patients with Parkinson's disease.

Authors:  Michele L Gregório; Marcela A S Pinhel; Caroline L Sado; Gabriela S Longo; Fábio N Oliveira; Gisele S Amorim; Marcelo A Nakazone; Greiciane M Florim; Camila M Mazeti; Denise P Martins; Waldir A Tognola; Antonio C Brandão; Sidney Pinheiro Júnior; Moacir F de Godoy; Dorotéia R S Souza
Journal:  Biomed Res Int       Date:  2013-09-24       Impact factor: 3.411

3.  The genetic association between apolipoprotein E gene polymorphism and Parkinson disease: A meta-Analysis of 47 studies.

Authors:  Jianming Li; Jia Luo; Li Liu; Hui Fu; Liang Tang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

4.  Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases.

Authors:  K Minta; G Brinkmalm; S Janelidze; S Sjödin; E Portelius; E Stomrud; H Zetterberg; K Blennow; O Hansson; U Andreasson
Journal:  Alzheimers Res Ther       Date:  2020-02-13       Impact factor: 6.982

5.  Differences in MTHFR and LRRK2 variant's association with sporadic Parkinson's disease in Mexican Mestizos correlated to Native American ancestry.

Authors:  Elizabeth Romero-Gutiérrez; Paola Vázquez-Cárdenas; Hortensia Moreno-Macías; José Salas-Pacheco; Teresa Tusié-Luna; Oscar Arias-Carrión
Journal:  NPJ Parkinsons Dis       Date:  2021-02-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.